
2 July 2026 - Small countries in a big world can choose to be nimble or they can choose to be stupid.
When it comes to medicines, New Zealand has chosen the second path. Rather than recognising authorisations provided by better-resourced overseas drug approval agencies, New Zealand requires local approval for new medicines.